Early Prediction of Response to Chemoradiotherapy for Head and Neck Cancer Reliability of Restaging With Combined Positron Emission Tomography and Computed Tomography

被引:33
|
作者
Malone, James P. [1 ]
Gerberi, Michael A. T. [1 ]
Vasireddy, Syam [2 ,4 ]
Hughes, Larry F. [1 ]
Rao, Krishna [3 ]
Shevlin, Bruce [5 ]
Kuhn, Matthew [2 ,4 ]
Collette, Dean [2 ,4 ]
Tennenhouse, Joel [2 ,4 ]
Robbins, K. Thomas [1 ]
机构
[1] So Illinois Univ, Sch Med, Dept Surg, Springfield, IL 62794 USA
[2] So Illinois Univ, Sch Med, Dept Radiol, Springfield, IL 62794 USA
[3] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL 62794 USA
[4] St Johns Hosp, Dept Radiol, Springfield, IL USA
[5] St Johns Hosp, Dept Radiat Oncol, Springfield, IL USA
关键词
SQUAMOUS-CELL CARCINOMA; STAGE-IV HEAD; RADIATION-THERAPY; FOLLOW-UP; FDG PET; DISSECTION; CHEMORADIATION; RADIOTHERAPY; UTILITY; CT;
D O I
10.1001/archoto.2009.152
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To assess the role of combined positron emission tomography and computed tomography (PET-CT) in predicting early treatment response at the primary site and in the neck after chemoradiotherapy (CRT) for advanced squamous cell carcinoma of the head and neck (SCCHN). Design: Retrospective analysis with a median follow-up of 24 months. Setting: Academic, tertiary referral center. Patients and Interventions: Thirty-one patients who were treated with concomitant intra-arterial CRT underwent PET-CT 6 to 8 weeks after the completion of treatment. Patients with findings on the physical examination, CT, or PET-CT indicative of persistent disease underwent appropriate surgical intervention for pathological assessment. Patients with a complete clinical response were observed with routine follow-up physical examination for disease recurrence. No evidence of disease at least 6 months after the completion of PET-CT was considered confirmation of complete clinical response. Main Outcome Measures: Presence or absence of residual or recurrent disease during the follow-up period was used to calculate the sensitivity, specificity, and positive and negative predictive values of PET-CT for the primary site and the neck. Results: Assessment of tumor response at the primary site with PET-CT had a sensitivity, specificity, and positive and negative predictive values of 83%, 54%, 31%, and 92%, respectively. In patients with pretreatment N1 to N3 disease, the sensitivity, specificity, and positive and negative predictive values of posttreatment PET-CT were 75%, more than 94%, more than 75%, and 94%, respectively, and the specificity and negative predictive value for patients with pretreatment N0 disease in the neck were 92% and more than 92%, respectively. Conclusions: Negative PET-CT findings accurately determine early disease response at the primary site and in the neck. False-positive findings are common at the primary site. Patients with a negative PET-CT finding after the completion of intra-arterial CRT do not require surgical intervention.
引用
收藏
页码:1119 / 1125
页数:7
相关论文
共 50 条
  • [1] Positron emission tomography/computed tomography for staging and restaging of head and neck cancer: comparison with positron emission tomography read together with contrast-enhanced computed tomography
    Goerres, Gerhard W.
    Schuknecht, Bernhard
    Schmid, Daniel T.
    Stoeckli, Sandro J.
    Hany, Thomas F.
    CLINICAL IMAGING, 2008, 32 (06) : 431 - 437
  • [2] Role of Positron Emission Tomography- Computed Tomography in Head and Neck Cancer
    Cashman, Emma C.
    MacMahon, Peter J.
    Shelly, Martin J.
    Kavanagh, Eoin C.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2011, 120 (09): : 593 - 602
  • [3] Role of Positron Emission Tomography/Computed Tomography (PET/CT) in Head and Neck Cancer
    Escott, Edward J.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2013, 51 (05) : 881 - +
  • [4] The Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Cancer after Radical Chemoradiotherapy: a Single Institution Experience
    Nelissen, C.
    Sherriff, J.
    Jones, T.
    Guest, P.
    Colley, S.
    Sanghera, P.
    Hartley, A.
    CLINICAL ONCOLOGY, 2017, 29 (11) : 753 - 759
  • [5] Positron emission tomography in cancer of the head and neck
    Hain, SF
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2005, 43 (01): : 1 - 6
  • [6] Positron emission tomography in head and neck cancer
    Oyen, W.
    Schinagl, D.
    Vogel, W.
    Wensing, B.
    Troost, E.
    Merkx, M.
    Marres, H.
    VandenHoogen, F.
    Kaanders, J.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S5 - S6
  • [7] Positron emission tomography-computed tomography protocol considerations for head and neck cancer imaging
    Escott, Edward J.
    SEMINARS IN ULTRASOUND CT AND MRI, 2008, 29 (04) : 263 - 270
  • [8] Quarter Century Positron Emission Tomography/Computed Tomography Transformation of Oncology Head and Neck Cancer
    Subramaniam, Rathan M.
    PET CLINICS, 2024, 19 (02) : 125 - 129
  • [9] Positron emission tomography/computed tomography imaging of head and neck tumors: An atlas
    Graham, MM
    Menda, Y
    SEMINARS IN NUCLEAR MEDICINE, 2005, 35 (04) : 220 - 252
  • [10] Positron emission tomography/computed tomography for target delineation in head and neck cancers
    Ahn, Peter H.
    Garg, Madhur K.
    SEMINARS IN NUCLEAR MEDICINE, 2008, 38 (02) : 141 - 148